NEWS

MicroVention Announces First Patient Enrolled in the STRAIT Study with t...

Aliso Viejo, CA – April 20, 2022 – MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke.

A WEB nightmare situation to face

Evolve: Early Experience (Symposium)

Day 1 - Back together again in Miami

Day 2 - The practice of INR advances for us all!

Access #LINNCAmericas streaming now!

Ángel Chamorro interview - The CHOICE Randomized Clinical Trial

ACom Aneurysm Recurrence treated with Flow diverter

Tandem occlusion with workflow issue

Incidental distal PICA Aneurysm treated with FD